The Trump administration is making a significant effort to reduce the cost of weight loss drugs. Its agreement with ...

A new treatment combining two hormones can reduce appetite, according to new research. This early study provides 'first in human' evidence that a combined therapy using the hormones glucagon and ...

The next wave of obesity drugs is coming soon. Drug companies are racing to develop GLP-1 drugs following the blockbuster success of Novo Nordisk’s Ozempic and Wegovy and Eli Lilly’s Mounjaro and ...

A major new clinical trial involving more than 1,600 people has found that a GLP-1 pill form of the drug orforglipron works ...

Glucagon, a hormone involved in regulating appetite, loses its ability to help obese people feel full after a meal, but it continues to suppress hunger pangs in people with type 1 diabetes, according ...

Remedy Meds is an online consumer health and pharmacy platform that provides access to compounded glucagon-like peptide-one ...

Nanosized particles that release glucagon, the hormone responsible for raising blood glucose levels, on-demand could mean that diabetics don’t need to worry about potentially dangerous low blood sugar ...

New insights into the actions of the hormone glucagon are provided by a recent study in rodents, which shows that glucagon can suppress hepatic glucose production by acting through the mediobasal ...

A critical piece of the puzzle to build an artificial pancreas for diabetics has been solved with some unexpected tools: lactose and a smartphone. This is an important step toward untethering Type 1 ...